(19)
(11) EP 0 951 564 A1

(12)

(43) Date of publication:
27.10.1999 Bulletin 1999/43

(21) Application number: 97910545.0

(22) Date of filing: 30.10.1997
(51) International Patent Classification (IPC): 
G01N 33/ 50( . )
C07K 14/ 72( . )
C12Q 1/ 68( . )
C07K 14/ 575( . )
C12N 15/ 00( . )
G01N 33/ 15( . )
(86) International application number:
PCT/GB1997/002988
(87) International publication number:
WO 1998/020158 (14.05.1998 Gazette 1998/19)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
SI

(30) Priority: 01.11.1996 GB 19960022866
01.11.1996 GB 19960022867
01.11.1996 GB 19960022865
01.11.1996 GB 19960022869
01.11.1996 GB 19960022847
01.11.1996 GB 19960022849
01.11.1996 GB 19960022851
01.11.1996 GB 19960022870
01.11.1996 GB 19960022868
01.11.1996 GB 19960022848
01.11.1996 GB 19960022850

(71) Applicant: SMITHKLINE BEECHAM PLC
Brentford, Middlesex TW8 9EP (GB)

(72) Inventor:
  • BEELEY, Lee James, SmithKline Beecham Pharma.
    Harlow, Essex CM19 5AW (GB)

(74) Representative: Rutter, Keith, Dr., et al 
SmithKline Beecham plc Corporate Intellectual Property, Two New Horizons Court
Brentford, Middlesex TW8 9EP
Brentford, Middlesex TW8 9EP (GB)

   


(54) METHOD FOR THE DETECTION OF COMPOUNDS THAT MODULATE THE EFFECTS OF THE OBESE (OB) PROTEIN